Effects on Recovery of Children of Intravenous Formulation of Fentanyl Citrate and Midazolam Orally for Premedication
Condition(s) studied
Investigational drug(s) / intervention(s)
Fentanyl Citrate: Intravenous Formulation of Fentanyl Citrate and Midazolam Administered Orally for Premedication
Study summary
To study and compare the efficacy of intravenous formula of fentanyl citrate and midazolam administered orally for premedication in paediatric surgical patients. Primary objectives will be the effect of both premedicants on recovery. The secondary outcomes will be time of onset and level of sedation, acceptance of premedication, and adverse effects. Sixty paediatric patients of either sex, in the age group of 2-8 years, with the American Society of Anaesthesiologists (ASA) Physical status I, posted for elective Genito-urological surgeries under general anaesthesia (GA) will be studied after clearance from the Institutional Ethics Committee and after obtaining written informed consent from a parent or a legal guardian
Eligibility
Primary outcome measure(s)
- effect of both premedicants on recovery — immediately after the surgery average 2 hours postoperative
1\. The quality of recovery will be evaluated using the three objective components in the modified pain/discomfort scale. Each variable scoring 0-2 points (best to worst). If the total score on the pain/discomfort scale at any evaluation point exceeded 3, the child will be regarded as suffering from postanaesthetic excitement. score 0 1 2 Crying Not crying Responding to pain Not responding to comforting Moving None Restless Thrashing Agitation Asleep/calm Mild agitation Sever agitation/Hysterical
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Ahmed S. Shehab | Alexandria | Alexandria Governorate |
More Alexandria University trials in Egypt
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05500599 on ClinicalTrials.gov ↗ ← All trials in Egypt